-+ 0.00%
-+ 0.00%
-+ 0.00%

Tvardi Therapeutics Q1 EPS $(0.73) Beats $(0.74) Estimate

Benzinga·05/08/2026 11:11:06
Listen to the news
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.74) by 1.35 percent. This is a 77.33 percent increase over losses of $(3.22) per share from the same period last year.